The 2014 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

Canadian Journal of Cardiology

Volumn 30, Issue 5, 2014, Pages 485-501

  Dasgupta, Kaberi ^a   Quinn, Robert R ^b   Zarnke, Kelly B ^c   Rabi, Doreen M ^b   Ravani, Pietro ^b   Daskalopoulou, Stella S ^a   Rabkin, Simon W ^d   Trudeau, Luc ^e   Feldman, Ross D ^f   Cloutier, Lyne ^g   Prebtani, Ally ^h   Herman, Robert J ^b   Bacon, Simon L ⁱ   Gilbert, Richard E ^j   Ruzicka, Marcel ^k   McKay, Donald W ^l   Campbell, Tavis S ^c   Grover, Steven ^m   Honos, George ⁿ   Schiffrin, Ernesto L ^o   Bolli, Peter ^p   Wilson, Thomas W ^q   Lindsay, Patrice ^r   Hill, Michael D ^s   Coutts, Shelagh B ^s   Gubitz, Gord ^t   Gelfer, Mark ^d   Vallée, Michel ^u   Prasad, G V Ramesh ^v   Lebel, Marcel ^w   McLean, Donna ^x   Arnold, J Malcolm O ^f   Moe, Gordon W ^j   Howlett, Jonathan G ^c   Boulanger, Jean Martin ^y   Larochelle, Pierre ^z   Leiter, Lawrence A ^aa   Jones, Charlotte ^ab   Ogilvie, Richard I ^ac   Woo, Vincent ^ad   Kaczorowski, Janusz ⁿ   Burns, Kevin D ^k   Petrella, Robert J ^f   Hiremath, Swapnil ^ae   Milot, Alain ^w   Stone, James A ^c   Drouin, Denis ^w   Lavoie, Kim L ^af   Lamarre Cliche, Maxime ^z   Tremblay, Guy ^ag   Hamet, Pavel ^ah   Fodor, George ^ai   Carruthers, S George ^aj   Pylypchuk, George B ^q   Burgess, Ellen ^b   Lewanczuk, Richard ^x   Dresser, George K ^ak   Penner, S Brian ^ad   Hegele, Robert A ^f   McFarlane, Philip A ^j   Khara, Milan ^d   Pipe, Andrew ^ai   Oh, Paul ^ac   Selby, Peter ^v   Sharma, Mukul ^al   Reid, Debra J ^am   Tobe, Sheldon W ^v   Padwal, Raj S ^x   Poirier, Luc ^ag   more..

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^j ST MICHAEL'S HOSPITAL   (Canada)

^k OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^l MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^m MONTREAL GENERAL HOSPITAL   (Canada)

ⁿ UNIVERSITÉ DE MONTRÉAL   (Canada)

^o MCGILL UNIVERSITY   (Canada)

^p Ambulatory Internal Medicine Teaching Clinic   (Canada)

^q UNIVERSITY OF SASKATCHEWAN   (Canada)

^r HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^s UNIVERSITY OF CALGARY   (Canada)

^t DALHOUSIE UNIVERSITY   (Canada)

^u MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^v UNIVERSITY OF TORONTO   (Canada)

^w UNIVERSITÉ LAVAL   (Canada)

^x UNIVERSITY OF ALBERTA   (Canada)

^y UNIVERSITÉ DE SHERBROOKE   (Canada)

^z CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^aa ST MICHAEL'S HOSPITAL   (Canada)

^ab UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^ac UNIVERSITY HEALTH NETWORK   (Canada)

^ad UNIVERSITY OF MANITOBA   (Canada)

^ae UNIVERSITY OF OTTAWA   (Canada)

^af UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^ag LAVAL UNIVERSITY   (Canada)

^ah CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^ai UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^aj University Health Network Departments of Medicine and Pharmacology University of Toronto ^*

^ak WESTERN UNIVERSITY   (Canada)

^al Canadian Stroke Network   (Canada)

^am DEPARTMENT OF NATIONAL DEFENCE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDRALAZINE; INDAPAMIDE; ISOSORBIDE DINITRATE; PERINDOPRIL; THIAZIDE DIURETIC AGENT;

ADULT DISEASE; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CALCIUM INTAKE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIETARY REFERENCE INTAKE; ECHOCARDIOGRAPHY; EDUCATION PROGRAM; EVIDENCE BASED PRACTICE; EXERCISE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; ISCHEMIC HEART DISEASE; LABORATORY TEST; LOW DRUG DOSE; META ANALYSIS (TOPIC); PHEOCHROMOCYTOMA; POTASSIUM INTAKE; PRIMARY PREVENTION; RENOVASCULAR HYPERTENSION; SODIUM INTAKE; STRESS MANAGEMENT; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CANADA; HEALTH PROMOTION; HUMANS; HYPERTENSION; LIFE STYLE; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROGRAM EVALUATION;

EID: 84899658037     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.02.002     Document Type: Article

References (58)

1. McAlister F.A., Wilkins K., Joffres M., et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
2. Robitaille C., Dai S., Waters C., et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012, 184:E49-E56.
3. Kannel W.B. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 275:1571-1576.
4. Yusuf S., Hawkins S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
5. Chow C.K., Teo K.K., Rangarajan S., et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013, 310:959-968.
6. Lim S.S., Vos T., Flaxman A.D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260.
7. Feldman R.D., Campbell N., Larochelle P., et al. 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. CMAJ 1999, 161(Suppl 12):S1-17.
8. Zarnke K.B., Levine M., McAlister F.A., et al. The 2000 Canadian recommendations for the management of hypertension: part two-diagnosis and assessment of people with high blood pressure. Can J Cardiol 2001, 17:1249-1263.
9. Zarnke K.B., McAlister F.A., Campbell N.R., et al. The 2001 Canadian recommendations for the management of hypertension: Part one-assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. Can J Cardiol 2002, 18:604-624.
10. McAlister F.A., Zarnke K.B., Campbell N.R., et al. The 2001 Canadian recommendations for the management of hypertension: part two-therapy. Can J Cardiol 2002, 18:625-641.
11. Hemmelgarn B.R., Zarnke K.B., Campbell N.R., et al. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: part I-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2004, 20:31-40.
12. Khan N.A., McAlister F.A., Campbell N.R., et al. The 2004 Canadian recommendations for the management of hypertension: part II-therapy. Can J Cardiol 2004, 20:41-54.
13. Touyz R.M., Campbell N., Logan A., et al. The 2004 Canadian recommendations for the management of hypertension: part III-lifestyle modifications to prevent and control hypertension. Can J Cardiol 2004, 20:55-59.
14. Hemmelgarn B.R., McAllister F.A., Myers M.G., et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2005, 21:645-656.
15. Khan N.A., McAlister F.A., Lewanczuk R.Z., et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol 2005, 21:657-672.
16. Hemmelgarn B.R., McAlister F.A., Grover S., et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: part I-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2006, 22:573-581.
17. Khan N.A., McAlister F.A., Rabkin S.W., et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol 2006, 22:583-593.
18. Padwal R.S., Hemmelgarn B.R., McAlister F.A., et al. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2007, 23:529-538.
19. Khan N.A., Hemmelgarn B., Padwal R., et al. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2007, 23:539-550.
20. Padwal R.S., Hemmelgarn B.R., Khan N.A., et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2008, 24:455-463.
21. Khan N.A., Hemmelgarn B., Herman R.J., et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2008, 24:465-475.
22. Padwal R.S., Hemmelgarn B.R., Khan N.A., et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2009, 25:279-286.
23. Khan N.A., Hemmelgarn B., Herman R.J., et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2009, 25:287-298.
24. Quinn R.R., Hemmelgarn B.R., Padwal R.S., et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2010, 26:241-248.
25. Hackam D.G., Khan N.A., Hemmelgarn B.R., et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2010, 26:249-258.
26. Rabi D.M., Daskalopoulou S.S., Padwal R.S., et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011, 27:415-433.
27. Daskalopoulou S.S., Khan N.A., Quinn R.R., et al. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2012, 28:270-287.
28. Hackam D.G., Quinn R.R., Ravani P., et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2013, 29:528-542.
29. McAlister F.A. The Canadian Hypertension Education Program-a unique Canadian initiative. Can J Cardiol 2006, 22:559-564.
30. Brouwers M.C., Kho M.E., Browman G.P., et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010, 182:E839-E842.
31. Bennett C.M., Guo M., Dharmage S.C. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007, 24:333-343.
32. Hu Y., Liu W., Chen Y., et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010, 47:231-236.
33. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013, 37(suppl 1):S1-212.
34. Sacks F., Svetkey L., Vollmer W., et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001, 344:3-10.
35. Moore T.J., Vollmer W.M., Appel L.J., et al. Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension 1999, 34:472-477.
36. Karanja N.M., Obarzanek E., Lin P.H., et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc 1999, 99(suppl 8):S19-S27.
37. Appel L., Moore T., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997, 336:1117-1124.
38. He F.J., Li J., Macgregor G.A. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013, 346:f1325.
39. Aburto N.J., Ziolkovska A., Hooper L., et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 2013, 346:f1326.
40. Institute of Medicine of the National Academies. Sodium intake in populations: assessment of evidence. Available at: Accessed March 19, 2014. http://www.iom.edu/sodiumconsequences.
41. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358:1887-1898.
42. Beckett N., Peters R., Tuomilehto J., et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2012, 344:d7541.
43. Gueyffier F., Bulpitt C., Boissel J.P., et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet 1999, 353:793-796.
44. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755-1762.
45. Hansson L., Zanchetti A. The hypertension optimal treatment study (the HOT study). Blood Press 1993, 2:62-68. for the HOT Study Group.
46. Calonge N., Petitti D.B., DeWitt T.G., Gordis L. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 150:396-404.
47. Rothwell P.M., Fowkes F.G., Belch J.F., et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011, 377:31-41.
48. Vandvik P.O., Lincoff A.M., Gore J.M., et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [erratum in 2012;141:1129]. Chest 2012, 141(suppl 2):e637S-e668S.
49. Messerli F.H., Mancia G., Conti C.R., et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Ann Intern Med 2006, 144:884-893.
50. Bangalore S., Messerli F.H., Wun C.C., et al. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J 2010, 31:2897-2908.
51. Bangalore S., Qin J., Sloan S., Murphy S.A., Cannon C.P. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation 2010, 122:2142-2151.
52. Fagard R.H., Staessen J.A., Thijs L., et al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 2007, 167:1884-1891.
53. Rabkin S.W., Waheed A., Poulter R.S., Wood D. Myocardial perfusion pressure in patients with hypertension and coronary artery disease: implications for DBP targets in hypertension management. J Hypertens 2013, 31:975-982.
54. Bangalore S., Kumar S., Volodarskiy A., Messerli F.H. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials. Heart 2013, 99:601-613.
55. Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Reboldi G. Aggressive blood pressure lowering is dangerous: the J-curve: con side of the argument. Hypertension 2013. [Epub ahead of print].
56. Anderson C.S., Heeley E., Huang Y., et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013, 368:2355-2365.
57. Butcher K.S., Jeerakathil T., Hill M., et al. The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. Stroke 2013, 44:620-626.
58. Benavente O.R., Coffey C.S., Conwit R., et al. Blood pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013, 382:507-515.